Search research articles
Contact Us
Filters
Showing results (21-30 of 61) with videos related to
Page
of 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2016
PARP inhibition in BRCA2-mutated prostate cancer
C Nientiedt, Y Tolstov, A-L Volckmar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2016
Targeted next-generation sequencing identifies molecular subgroups in squamous cell carcinoma of the head and neck with distinct outcome after concurrent chemoradiation
I Tinhofer, A Stenzinger, T Eder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 4, 2019
Optimizing panel-based tumor mutational burden (TMB) measurement
J Budczies, M Allgäuer, K Litchfield, et al.
International Journal of Antimicrobial Agents
|
May 17, 2017
Chloroquine enhances the antimycobacterial activity of isoniazid and pyrazinamide by reversing inflammation-induced macrophage efflux
U Matt, P Selchow, M Dal Molin, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
June 27, 2013
Radiosensitization by histone deacetylase inhibition in an osteosarcoma mouse model
C Blattmann, M Thiemann, A Stenzinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 13, 2022
Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
A Vogel, J Bridgewater, J Edeline, et al.
International Journal of Antimicrobial Agents
|
November 19, 2017
Corrigendum to 'Chloroquine enhances the antimycobacterial activity of isoniazid and pyrazinamide by reversing inflammation-induced macrophage efflux' [The International Journal of Antimicrobial Agents 50/1 (2017) 55-62]
U Matt, P Selchow, M Dal Molin, et al.
British Journal of Cancer
|
October 19, 2013
Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer
B Goeppert, L Frauenschuh, M Zucknick, et al.
Der Pathologe
|
May 16, 2019
[From panel diagnostics to comprehensive genomic analysis : Infobesity or empowerment?]
J Leichsenring, D Kazdal, C Ploeger, et al.
ESMO Open
|
November 27, 2025
Regulation of laboratory-developed tests and in-house in vitro diagnostic medical devices in the United States and the European Union-a comparative overview
A Kahles, A-L Volckmar, H Goldschmid, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 61) with videos related to
Sort By:
Page
of 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2016
PARP inhibition in BRCA2-mutated prostate cancer
C Nientiedt, Y Tolstov, A-L Volckmar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2016
Targeted next-generation sequencing identifies molecular subgroups in squamous cell carcinoma of the head and neck with distinct outcome after concurrent chemoradiation
I Tinhofer, A Stenzinger, T Eder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 4, 2019
Optimizing panel-based tumor mutational burden (TMB) measurement
J Budczies, M Allgäuer, K Litchfield, et al.
International Journal of Antimicrobial Agents
|
May 17, 2017
Chloroquine enhances the antimycobacterial activity of isoniazid and pyrazinamide by reversing inflammation-induced macrophage efflux
U Matt, P Selchow, M Dal Molin, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
June 27, 2013
Radiosensitization by histone deacetylase inhibition in an osteosarcoma mouse model
C Blattmann, M Thiemann, A Stenzinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 13, 2022
Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
A Vogel, J Bridgewater, J Edeline, et al.
International Journal of Antimicrobial Agents
|
November 19, 2017
Corrigendum to 'Chloroquine enhances the antimycobacterial activity of isoniazid and pyrazinamide by reversing inflammation-induced macrophage efflux' [The International Journal of Antimicrobial Agents 50/1 (2017) 55-62]
U Matt, P Selchow, M Dal Molin, et al.
British Journal of Cancer
|
October 19, 2013
Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer
B Goeppert, L Frauenschuh, M Zucknick, et al.
Der Pathologe
|
May 16, 2019
[From panel diagnostics to comprehensive genomic analysis : Infobesity or empowerment?]
J Leichsenring, D Kazdal, C Ploeger, et al.
ESMO Open
|
November 27, 2025
Regulation of laboratory-developed tests and in-house in vitro diagnostic medical devices in the United States and the European Union-a comparative overview
A Kahles, A-L Volckmar, H Goldschmid, et al.
Page
of 7